We found that diabetes status was a marginally significant effect modifier between intensive lipid-lowering and coronary heart disease risk reduction.
← all excerpts
Efficacy of more intensive lipid-lowering therapy on cardiovascular diseases: a systematic review and meta-analysis.
1
—
—